THERALASE TECHNOLOGIES INC (TLT.CA) Stock Income Statement
TSX-V:TLT - TSX Venture Exchange - CA88337V1004 - Common Stock - Currency: CAD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 986.70K | 1.07M | 1.14M | 780.60K | 929.10K | |||
| Cost Of Goods | 476.40K | 508.20K | 510.40K | 470.70K | 659.40K | |||
| Gross Profit | 510.20K | 562.10K | 628.20K | 309.90K | 269.70K | |||
| Operating Expenses | 4.87M | 5.16M | 5.86M | 4.85M | 5.97M | |||
| Research and Development | 2.59M | 2.77M | 4.05M | 2.75M | 3.31M | |||
| Selling, General, and Administrative Expenses | 2.03M | 2.13M | 1.53M | 1.85M | 2.42M | |||
| Operating Income | -4.36M | -4.59M | -5.23M | -4.54M | -5.70M | |||
| Interest Income/Expense | 34.60K | 23.40K | -18.70K | -1.40K | 98.20K | |||
| Non Recurring Items | N/A | 0.00 | 15.00K | 131.90K | N/A | |||
| Income Before Taxes | -4.33M | -4.57M | -5.24M | -4.41M | -5.60M | |||
| Net Income | -4.33M | -4.57M | -5.24M | -4.41M | -5.60M | |||
| EBITDA | -4.09M | -4.31M | -4.92M | -4.27M | -5.42M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.02 | -0.02 | -0.03 | -0.02 | -0.03 | |||
| Non GAAP EPS | -0.02 | N/A | N/A | -0.03 | -0.03 | |||
| Statistics | ||||||||
| Gross Profit Margin | 51.71% | 52.52% | 55.17% | 39.70% | 29.03% | |||
| Profit Margin | -438.74% | -427.07% | -459.80% | -565.09% | -602.57% | |||
| Operating Profit Margin | -442.25% | -429.25% | -459.47% | -581.80% | -613.14% | |||
All data in CAD